Logo image
Se connecter
Pathophysiology and abnormalities of hemostasis in intensive care patients with Covid-19
Article de revue   Avec comité de lecture

Pathophysiology and abnormalities of hemostasis in intensive care patients with Covid-19

Berangere Joly, Nicolas Beranger, Maxime Delrue, Marie Neuwirth, Nathalie Itzhar-Baikian, Arezki Hadj-Ali, Alain Stepanian, Agnes Veyradier et Virginie Siguret
Hématologie, Vol.27(1), pp.10-18
01/01/2021

Résumé

Hematology Life Sciences & Biomedicine Science & Technology
Coronavirus disease 2019 (Covid-19), a severe acute respiratory syndrome caused by coronavirus 2 (Sars-CoV-2), has now spread to all continents. About 5-10 % of Covid-19 patients require intensive care unit admission and mechanical ventilation. Critically ill Covid-19 patients are prone to develop hypoxia, excessive inflammation and frequent thrombotic manifestations affecting both the macrocirculation and the microcirculation.

Indicateurs

1 Consultations de la notice

Détails

Logo image